Liquan Huang

The paper designs and validates high-affinity RNA aptamers for SARS-CoV-2 that match the binding affinity of neutralizing antibodies.

AlphaVacc optimizes neoantigen peptides using deep reinforcement learning, improving binding affinity and T cell response in experimental validation.

The paper shows inflammation increases Tas2r gene accessibility via chromatin remodeling, leading to heightened bitter taste responses in mice.